Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor

J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S372-4. doi: 10.1097/JTO.0b013e31826df03e.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Hepatocyte Growth Factor / metabolism*
  • Humans
  • Molecular Targeted Therapy*
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Protein Binding
  • Proto-Oncogene Proteins c-met / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-met / metabolism

Substances

  • Antineoplastic Agents
  • Hepatocyte Growth Factor
  • Proto-Oncogene Proteins c-met